These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32193509)

  • 1. Double-Stranded DNA and NETs Components in Relation to Clinical Outcome After ST-Elevation Myocardial Infarction.
    Langseth MS; Helseth R; Ritschel V; Hansen CH; Andersen GØ; Eritsland J; Halvorsen S; Fagerland MW; Solheim S; Arnesen H; Seljeflot I; Opstad TB
    Sci Rep; 2020 Mar; 10(1):5007. PubMed ID: 32193509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose associated NETosis in patients with ST-elevation myocardial infarction: an observational study.
    Helseth R; Knudsen EC; Eritsland J; Opstad TB; Arnesen H; Andersen GØ; Seljeflot I
    BMC Cardiovasc Disord; 2019 Oct; 19(1):221. PubMed ID: 31615411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Markers of neutrophil extracellular traps are associated with adverse clinical outcome in stable coronary artery disease.
    Langseth MS; Opstad TB; Bratseth V; Solheim S; Arnesen H; Pettersen AÅ; Seljeflot I; Helseth R
    Eur J Prev Cardiol; 2018 May; 25(7):762-769. PubMed ID: 29473463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement activation in association with clinical outcomes in ST-elevation myocardial infarction.
    Kluge KE; Langseth MS; Andersen GØ; Halvorsen S; Opstad TB; Arnesen H; Tønnessen T; Seljeflot I; Helseth R
    Am Heart J Plus; 2022 Dec; 24():100228. PubMed ID: 38560636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil extracellular trap components and myocardial recovery in post-ischemic acute heart failure.
    Langseth MS; Andersen GØ; Husebye T; Arnesen H; Zucknick M; Solheim S; Eritsland J; Seljeflot I; Opstad TB; Helseth R
    PLoS One; 2020; 15(10):e0241333. PubMed ID: 33119664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Culprit site extracellular DNA and microvascular obstruction in ST-elevation myocardial infarction.
    Mangold A; Ondracek AS; Hofbauer TM; Scherz T; Artner T; Panagiotides N; Beitzke D; Ruzicka G; Nistler S; Wohlschläger-Krenn E; Winker R; Quehenberger P; Traxler-Weidenauer D; Spannbauer A; Gyöngyösi M; Testori C; Lang IM
    Cardiovasc Res; 2022 Jun; 118(8):2006-2017. PubMed ID: 34173822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement Activation in Association with Markers of Neutrophil Extracellular Traps and Acute Myocardial Infarction in Stable Coronary Artery Disease.
    Kluge KE; Langseth MS; Opstad TB; Pettersen AÅ; Arnesen H; Tønnessen T; Seljeflot I; Helseth R
    Mediators Inflamm; 2020; 2020():5080743. PubMed ID: 32308555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Time Course of Markers of Neutrophil Extracellular Traps in Patients Undergoing Revascularisation for Acute Myocardial Infarction or Stable Angina Pectoris.
    Helseth R; Solheim S; Arnesen H; Seljeflot I; Opstad TB
    Mediators Inflamm; 2016; 2016():2182358. PubMed ID: 28074081
    [No Abstract]   [Full Text] [Related]  

  • 9. Neutrophil Extracellular Trap Components Associate with Infarct Size, Ventricular Function, and Clinical Outcome in STEMI.
    Helseth R; Shetelig C; Andersen GØ; Langseth MS; Limalanathan S; Opstad TB; Arnesen H; Hoffmann P; Eritsland J; Seljeflot I
    Mediators Inflamm; 2019; 2019():7816491. PubMed ID: 31772506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short and long-term survival after primary percutaneous coronary intervention in young patients with ST-elevation myocardial infarction.
    Waziri H; Jørgensen E; Kelbæk H; Stagmo M; Pedersen F; Lagerqvist B; James S; Køber L; Wachtell K
    Int J Cardiol; 2016 Jan; 203():697-701. PubMed ID: 26583845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Efficacy of Staged Percutaneous Coronary Intervention During Index Admission for ST-Elevation Myocardial Infarction With Multivessel Coronary Disease (Insights from the University of Ottawa Heart Institute STEMI Registry).
    Russo JJ; Wells GA; Chong AY; So DY; Glover CA; Froeschl MP; Hibbert B; Marquis JF; Dick A; Blondeau M; Bernick J; Labinaz M; Le May MR;
    Am J Cardiol; 2015 Oct; 116(8):1157-62. PubMed ID: 26282725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of culprit artery double-stranded DNA in ST-segment elevated myocardial infarction.
    Wang X; Yang D; Liu J; Fan X; Ma A; Liu P
    Sci Rep; 2018 Jun; 8(1):9294. PubMed ID: 29915211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis of elderly patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention in 2001 to 2011: A report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR) registry.
    Velders MA; James SK; Libungan B; Sarno G; Fröbert O; Carlsson J; Schalij MJ; Albertsson P; Lagerqvist B
    Am Heart J; 2014 May; 167(5):666-73. PubMed ID: 24766976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of myeloperoxidase concentration in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Kacprzak M; Zielinska M
    Int J Cardiol; 2016 Nov; 223():452-457. PubMed ID: 27544604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance and relationship of worst lead residual ST segment elevation with myocardial damage assessed by cardiovascular MRI in myocardial infarction.
    Rommel KP; Baum A; Mende M; Desch S; Gutberlet M; Schuler G; Thiele H; Eitel I
    Heart; 2014 Aug; 100(16):1257-63. PubMed ID: 25049315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of low level of high-density lipoprotein-cholesterol sampled in overnight fasting state on the clinical outcomes in patients with acute myocardial infarction (difference between ST-segment and non-ST-segment-elevation myocardial infarction).
    Ji MS; Jeong MH; Ahn YK; Kim YJ; Chae SC; Hong TJ; Seong IW; Chae JK; Kim CJ; Cho MC; Rha SW; Bae JH; Seung KB; Park SJ;
    J Cardiol; 2015 Jan; 65(1):63-70. PubMed ID: 25242301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prasugrel versus clopidogrel in patients with ST-segment elevation myocardial infarction according to timing of percutaneous coronary intervention: a TRITON-TIMI 38 subgroup analysis (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis In Myocardial Infarction 38).
    Udell JA; Braunwald E; Antman EM; Murphy SA; Montalescot G; Wiviott SD
    JACC Cardiovasc Interv; 2014 Jun; 7(6):604-12. PubMed ID: 24947719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Increased postprocedural neutrophil count is an independent predictive factor of poor prognosis in acute ST elevation myocardial infarction patients treated with percutaneous coronary intervention].
    He R; Yang ZH; Li HY; Guo LJ; Zhang FC; Niu J; Zhang YZ; Wang GS; Gao W
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Jan; 37(1):44-8. PubMed ID: 19671351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left circumflex artery-related myocardial infarction: does ST elevation matter? Results from the Euro Heart Survey PCI registry.
    Bauer T; Gitt AK; Hochadel M; Möllmann H; Nef H; Weidinger F; Zahn R; Hamm CW; Marco J; Zeymer U
    Int J Cardiol; 2013 Oct; 168(6):5239-42. PubMed ID: 23998547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of biohumoral markers of necrosis and inflammation in patients with right ventricular myocardial infarction.
    Orozović V; Rafajlovski S; Gligić B; Miailović Z; Obradović S; Ratković N; Djenić N; Baskot B
    Prilozi; 2007 Jul; 28(1):23-38. PubMed ID: 17921916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.